firefly wrote:
>
> NEWS
>
> Cancer clinicians have long known that hypoxie tumors--which thrive
> where oxygen is scarce--are much more resistant to radiation and
> chemotherapy than other tumors. Now, researchers at the Univ. of
> Pennsylvania Cancer Center have developed a drug, called EF 5 that
> helps doctors determine the oxygan content of a tumor and therefore
> better able to tailor cancer treatments to a patients needs.
> Source, Univ.
> Of Pa.
> Your friend Lillian
DEarest Lillian,
Thank you so much for the update and newsflash. Yes, each day more and
more HOPE and FDA approvals for treatments. Hang on everyone HOPE is on
the way.
God Bless
marty auslander
------------------------------------------------------------------------
This is an automatically-generated notice. If you'd like to be removed
from the mailing list, please visit the Medicine-On-Line Discussion Forum
at <http://www.meds.com/con_faq.html>, or send an email message to:
majordomo@lists.meds.com
with the subject line blank and the body of the message containing the line:
unsubscribe mol-cancer your-email-address
where the phrase your-email-address is replaced with your actual email
address.
------------------------------------------------------------------------
